Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Small extracellular vesicles inhibit NLRP3 inflammasome activation in diabetic retinopathy
Author Affiliations & Notes
  • Henry Louie
    Department of Ophthalmology, The University of Auckland Faculty of Medical and Health Sciences, Auckland, Auckland, New Zealand
  • Lola Mugisho
    Department of Ophthalmology, The University of Auckland Faculty of Medical and Health Sciences, Auckland, Auckland, New Zealand
  • Lawrence W Chamley
    Department of Obstetrics and Gynaecology, The University of Auckland Faculty of Medical and Health Sciences, Auckland, Auckland, New Zealand
  • Ilva D Rupenthal
    Department of Ophthalmology, The University of Auckland Faculty of Medical and Health Sciences, Auckland, Auckland, New Zealand
  • Footnotes
    Commercial Relationships   Henry Louie None; Lola Mugisho None; Lawrence Chamley None; Ilva Rupenthal None
  • Footnotes
    Support  Buchanan Charitable Foundation
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 840. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Henry Louie, Lola Mugisho, Lawrence W Chamley, Ilva D Rupenthal; Small extracellular vesicles inhibit NLRP3 inflammasome activation in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2024;65(7):840.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The nucleotide-binding oligomerisation domain-like receptor protein 3 (NLRP3) inflammasome is a multiprotein complex that forms part of the innate immune system. Recent studies have shown that the inflammasome pathway is upregulated in diabetic retinopathy (DR) resulting in the breakdown of the retinal pigment epithelium (RPE) barrier. It has been hypothesised that small extracellular vesicles (sEVs) may transport inflammasome-related cargos between cells which in turn contributes to DR pathogenesis. This study aimed to characterise sEVs secreted by retinal pigment epithelial cells (ARPE-19) grown under normal and DR-like conditions and assess their effects on inflammasome activation.

Methods : sEVs were isolated from ARPE-19 cell culture medium (basal sEVs) by ultracentrifugation at 100,000 g for 70 min at 4oC. To mimic DR-like conditions, ARPE-19 cells were exposed to high glucose and pro-inflammatory cytokines, tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) for 72 h (HG+Cyt sEVs). sEVs were characterized for size, concentration and morphology using nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Western blotting was used to determine the sEV cargo (NF-κB, IL-1β, NLRP3, cleaved caspase-1). Immunocytochemistry was performed to assess inflammasome markers (NLRP3, cleaved caspase-1) in response to sEV addition onto ARPE-19 cells grown under normal and DR-like conditions.

Results : HG+Cyt treatment increased sEV concentration relative to basal conditions. While sEV markers (CD9 and TSG101) were equally expressed in both groups, inflammasome markers (NLRP3 and cleaved caspase-1) were increased in HG+Cyt sEVs relative to basal sEVs. When added to normal ARPE-19 cells, HG+Cyt sEVs induced inflammasome activation, while basal sEVs added to injured ARPE-19 cells reduced inflammasome activation.

Conclusions : These findings support the hypothesis that sEVs can mediate inflammasome activation through their immunomodulatory cargo depending on the disease state and culture conditions. Further studies are necessary to determine whether other sEV cargo, such as miRNA, may also play a role in mediating the inflammasome.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×